|
|
February 8, 2011
A scientist working on drug screening is interesting in two things: first, to know whether the drug candidate is effective against cancer cells, and secondly, to understand the way the drug is killing cancer cells.
There is hope indeed, but only for those patients who have enough time to wait. Developing a new drug is an expensive and time-consuming process made even more difficult by today’s global recession.
January 26, 2011
Professor Rengul Cetin-Atalay is a passionate researcher of Bilkent University’s Genetics and Molecular Biology Department.The researchers at Bilkent University focus on screening possible drug candidates for liver cancer.
